Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2589_Библиотеки_им_академика_М_И_Перельмана
.pdf
ab
5.5 Retinal Haemorrhages inNeurological Disorders
https://t.me/medicina_free
Fig. 5.16 Optic disc oedema and haemorrhages in both eyes (a, b) of a patient with idiopathic intracranial
hypertension
95
5.5.3 Wernicke’s Encephalopathy
andRetinal Haemorrhages
Thiamine (Vitamin B1) deciency may cause a
life-threatening condition of central and peripheral neuropathy characterized by confusion,
ataxia, and ophthalmoplegia. While Carl
Wernicke noted the presence of optic disc swelling and retinal haemorrhages in his initial
patients, Cogan and Victor [56] did not nd ptosis, pupillary signs, optic disc swelling, or retinal
haemorrhages in any of patients with Wernicke’s
disease [56, 57]. Cogan’s study led to a misconception that the presence of retinal haemorrhages
ruled out Wernicke’s encephalopathy. Physicians
should know that Wernicke’s encephalopathy has
described retinal haemorrhages and optic disc
swelling. Their presence should not delay the
diagnosis of this rapidly fatal but quickly reversible disease [58–60].
and dilated retinal veins without tortuosity
(Fig.5.17). [63]. Occasionally peripheral retinal
haemorrhages may be seen in patients with
insulin- dependent diabetes who may show only
minimal, or no background retinopathy changes
[64].
5.5.5 Retinal Haemorrhages
inIncreased Intracranial
Pressure
Patients with increased intracranial pressure presenting with papilloedema often have supercial
retinal haemorrhages in the peripapillary area. In
patients with diabetes, hypertension, or central
retinal vein occlusion, retinal haemorrhages may
be seen even in the far periphery of the retina and
pose a diagnostic challenge [65].
5.5.6 Valsalva Retinopathy
5.5.4 Ocular Ischaemic Syndrome
Seemingly benign activities such as lifting
Midperipheral retinal haemorrhages are seen in a
vast majority of patients (more than 80%) with
ocular ischaemic syndrome due to severe obstruction of carotid arteries [61, 62].
Patients with carotid artery obstructive disease
remain asymptomatic for a long time. Peripheral
retinal dot and blot haemorrhages are accompanied by narrow or thread-like retinal arterioles
weights, a bout of forceful coughing, or straining
at stools etc., especially against a closed glottis
(Valsalva manoeuvre), may cause a sudden
increase in the intraabdominal and intrathoracic
pressure, which in the absence of valves in the
veins located above the heart leads to a spike in
the intravenous pressure in the upper part of the
body. This sudden increase in pressure gets trans-

96
ab
cd
https://t.me/medicina_free
5 Retinal Haemorrhages
Fig. 5.17 Retinal haemorrhages (black arrows) are
accompanied by narrow or even thread-like retinal arterioles (blue arrows) in both eyes (a, b) of a patient with
ocular ischaemic syndrome. Fluorescein angiography (c,
d) showed extensively non-perfused retina
mitted to the retinal veins and capillaries that
may rupture, resulting in a haemorrhage in the
subhyaloid or sub-ILM space or the retina leading to a sudden loss of vision (Fig. 5.18) [66].
The presence of two rings suggests the presence
of both sub-ILM and subhyaloid locations of the
blood [67]. The actual site of retinal vein rupture
has been documented in a patient who developed
preretinal and vitreous haemorrhage following
self-induced emesis [68]. Visual disturbances
discovered by a patient on waking up following
general anaesthesia may be due to the Valsalva
retinopathy caused by difcult intubation [69,
70].
The Valsalva retinopathy resolves spontaneously in a few days, and the patients who usually
report to the emergency department need nothing
Fig. 5.18 Massive subhyaloid (black arrows) and subILM haemorrhage (blue arrows) following a Valsalva
manoeuvre

References
https://t.me/medicina_free
97
more than reassurance. The physician looking
after the patient needs to be aware of this entity.
If the haemorrhage does not resolve spontaneously within 3weeks, Nd:YAG laser hyaloidotomy may drain the liqueed blood into a more
dependent part of the vitreous cavity with immediate improvement in the vision.
By and large, Valsalva retinopathy is unilateral
except when there may be an underlying retinal
pathology. Bilateral loss of vision due to Valsalva
retinopathy in a young woman during a normal
vaginal delivery necessitated vitreous surgery in
one eye to remove the haemorrhage [71].
While in the past, most of the cases of Valsalva
retinopathy were noted in the sub-ILM or subhyaloid space, with the availability of spectral
domain OCT, these haemorrhages are now
reported even in the deeper layers of the retina
that may necessitate the use of intravitreal TPA
and gas to displace the haemorrhage [72].
References
1. Li Z, Guo C, Nie D, Lin D, Zhu Y, Chen C, Xiang Y,
Xu F, Jin C, Zhang X, Yang Y, Zhang K, Zhao L, Zhang
P, Han Y, Yun D, Wu X, Yan P, Lin H. Development
and evaluation of a deep learning system for screening retinal hemorrhage based on ultra-Wideeld
fundus images. Transl Vis Sci Technol. 2020;9(2):3.
https://doi.org/10.1167/tvst.9.2.3. PMID: 32518708;
PMCID: PMC7255628.
2. Kumar A, Kumar P, Singh A, D S, Kaushik
J. Bilateral premacular sub-hyaloid hemorrhageunmasking COVID-19 induced pancytopenia. J Med
Virol. 2021;93(5):2576–7. https://doi.org/10.1002/
jmv.26752. Epub 2020 Dec 29. PMID: 33368339.
3. Sharma A, Upadhyaya A, Madan S, Singh P, Beri
S.Sub-internal limiting membrane haemorrhage following pancytopenia in megaloblastic anemia. Clin
Exp Optom. 2021;104(5):653–5. https://doi.org/10
.1080/08164622.2021.1878842. Epub 2021 Mar 1.
PMID: 33689650.
4. Baumal CR, Sarraf D, Bryant T, Gui W, Muakkassa N,
Pichi F, Querques G, Choudhry N, Teke MY, Govetto
A, Invernizzi A, Eliott D, Gaudric A, Cunha de Souza
E, Naysan J, Lembo A, Lee GC, Freund KB.Henle
bre layer haemorrhage: clinical features and pathogenesis. Br J Ophthalmol. 2021;105(3):374–80.
https://doi.org/10.1136/bjophthalmol- 2019- 315443.
Epub 2020 May 6. PMID: 32376610.
5. Au A, Hou K, Baumal CR, Sarraf D.Radial hemorrhage in Henle layer in macular telangiectasia type 2.
JAMA Ophthalmol. 2018;136(10):1182–5. https://
doi.org/10.1001/jamaophthalmol.2018.2979. PMID:
30054619; PMCID: PMC6233838.
6. Lu AQ, Prensky JG, Baker PS, Scott IU, Mahmoud
TH, Todorich B. Update on medical and surgical
management of submacular hemorrhage. Expert Rev
Ophthalmol. 2020;15(1):43–57. https://doi.org/10.10
80/17469899.2020.1725474.
7. Todorich B, Scott IU, Flynn HW Jr, Johnson
MW. Evolving strategies in the management of
submacular hemorrhage associated with choroidal
neovascularization in the anti-vascular endothelial growth factor era. Retina. 2011;31(9):1749–52.
https://doi.org/10.1097/IAE.0b013e31821504df.
PMID: 21562448.
8. Lee EJ, Kee HJ, Han JC, Kee C. Evidence-based
understanding of disc hemorrhage in glaucoma.
Surv Ophthalmol. 2021;66(3):412–22. https://doi.
org/10.1016/j.survophthal.2020.09.001. Epub 2020
Sep 17. PMID: 32949554.
9. Hwang JF, Lin CJ. Multilayered optic disc hemorrhages in adolescents. J Pediatr Ophthalmol
Strabismus. 2014;51(5):313–8. https://doi.
org/10.3928/01913913- 20140715- 01. Epub 2014 Jul
22. PMID: 25036104.
10. Kokame GT, Yamamoto I, Kishi S, Tamura A,
Drouilhet JH. Intrapapillary hemorrhage with
adjacent peripapillary subretinal hemorrhage.
Ophthalamology. 2004;111(5):926–30. https://doi.
org/10.1016/j.ophtha.2003.08.040. PMID: 15121370.
11. Zou M, Zhang Y, Huang X, etal. Demographic prole, clinical features, and outcome of peripapillary
subretinal hemorrhage: an observational study. BMC
Ophthalmol. 2020;20:156. https://doi.org/10.1186/
s12886- 020- 01426- 9.
12. Zhang X, Cheng X, Chen B, Sun X. Multimodal
imaging characteristics and presumed cause of
intrapapillary hemorrhage with adjacent peripapillary subretinal hemorrhage. Clin Ophthalmol.
2021;15:2583–90. https://doi.org/10.2147/OPTH.
S304861. PMID: 34177259; PMCID: PMC8219308.
13. Sibony P, Fourman S, Honkanen R, El Baba
F. Asymptomatic peripapillary subretinal hemorrhage: a study of 10 cases. J Neuroophthalmol.
2008;28(2):114–9. https://doi.org/10.1097/
WNO.0b013e318175cd90. PMID: 18562843.
14. Kaur B, Taylor D. Fundus hemorrhages in infancy.
Surv Ophthalmol. 1992;37(1):1–17. https://doi.
org/10.1016/0039- 6257(92)90002- b. PMID:
1509354.
15. Watts P, Maguire S, Kwok T, Talabani B, Mann
M, Wiener J, Lawson Z, Kemp A. Newborn retinal hemorrhages: a systematic review. J AAPOS.
2013;17(1):70–8. https://doi.org/10.1016/j.jaa-
pos.2012.07.012. Epub 2013 Jan 28. Erratum in: J
AAPOS. 2013 Jun;17(3):341. PMID: 23363882.
16. Duke-Elder S, Dobree JH, editors. System of ophthalmology, diseases of the retina, vol. X.London: Henry
Kimpton; 1967. p.140.

98
https://t.me/medicina_free
5 Retinal Haemorrhages
17. Cho IH, Kim MS, Heo NH, Kim SY. Birthrelated retinal hemorrhages: the Soonchunhyang
University Cheonan Hospital universal newborn
eye screening (SUCH-NES) study. PLoS One.
2021;16(11):e0259378. https://doi.org/10.1371/
journal.pone.0259378. PMID: 34752467; PMCID:
PMC8577753.
18. Sun L, Jiang Z, Li S, Liu J, Su M, Lu Y, Li Z, Ding
X.What is left after resolution of neonatal retinal hemorrhage: the longitudinal long-term outcome in foveal
structure and visual function. Am J Ophthalmol.
2021;226:182–90. https://doi.org/10.1016/j.
ajo.2021.01.028. Epub 2021 Feb 5. PMID: 33556380.
19. Kiffney GT Jr. The eye of the “battered child”. Arch
Ophthalmol. 1964;72:231–3. https://doi.org/10.1001/
archopht.1964.00970020231016. PMID: 14162948.
20. Togioka BM, Arnold MA, Bathurst MA, Ziegfeld SM,
Nabaweesi R, Colombani PM, Chang DC, Abdullah
F.Retinal hemorrhages and shaken baby syndrome: an
evidence-based review. J Emerg Med. 2009;37(1):98–
106. https://doi.org/10.1016/j.jemermed.2008.06.022.
Epub 2008 Dec 11. PMID: 19081701.
21. Binenbaum G, Forbes BJ. The eye in child abuse:
key points on retinal hemorrhages and abusive head
trauma. Pediatr Radiol. 2014;44 Suppl 4:S571–7.
https://doi.org/10.1007/s00247- 014- 3107- 9. Epub
2014 Dec 14. PMID: 25501729.
22. Thiblin I, Andersson J, Wester K, Högberg G, Högberg
U.Retinal haemorrhage in infants investigated for suspected maltreatment is strongly correlated with intracranial pathology. Acta Paediatr. 2022;111(4):800–8.
https://doi.org/10.1111/apa.16139. Epub 2021 Oct
28. PMID: 34617346.
23. Hansen JB, Killough EF, Moffatt ME, Knapp
JF. Retinal hemorrhages: abusive head trauma or
not? Pediatr Emerg Care. 2018;34(9):665–70. https://
doi.org/10.1097/PEC.0000000000001605. PMID:
30180101.
24. Levin AV. Retinal hemorrhages: advances in understanding. Pediatr Clin North Am. 2009;56(2):333–44.
https://doi.org/10.1016/j.pcl.2009.02.003. PMID:
19358919.
25. Binenbaum G, Reid JE, Rogers DL, Jensen AK,
Billinghurst LL, Forbes BJ.Patterns of retinal hemorrhage associated with pediatric cerebral sinovenous
thrombosis. J AAPOS. 2017;21(1):23–7. https://doi.
org/10.1016/j.jaapos.2016.10.004. Epub 2017 Jan 11.
PMID: 28087346.
26. Thau A, Saffren B, Anderst JD, Carpenter SL, Levin
AV.A review on clotting disorders and retinal hemorrhages: can they mimic abuse? Child Abuse
Negl. 2021;118:105070. https://doi.org/10.1016/j.
chiabu.2021.105070. Epub 2021 May 25. PMID:
34049052.
27. Quan SC, Skondra D. Case report: peripheral retinal ischemia and retinal neovascularization in von
Willebrand disease. Optim Vis Sci. 2021;98(4):418–
24. https://doi.org/10.1097/OPX.0000000000001670.
PMID: 33828041.
28. Carraro MC, Rossetti L, Gerli GC. Prevalence of
retinopathy in patients with anemia or thrombocytopenia. Eur J Haematol. 2001;67(4):238–44. https://
doi.org/10.1034/j.1600- 0609.2001.00539.x. PMID:
11860445.
29. Capua T, Cohen N, Anafy A, Greisman D, Levin D,
Rimon A.Routine funduscopy in immune thrombocytopenic purpura—is it really necessary? Eur J Pediatr.
2019;178(6):957–60. https://doi.org/10.1007/s00431-
019- 03371- 2. Epub 2019 Apr 2. PMID: 30937605.
30. Honig SE, Srinivasan A, Shields CL.Suprachoroidal
hemorrhage simulating melanoma in idiopathic
thrombocytopenic purpura. Ocul Oncol Pathol.
2019;5(3):162–6. https://doi.org/10.1159/000490390.
Epub 2018 Oct 11. PMID: 31049321; PMCID:
PMC6489043.
31. Kaur N, Nair V, Sharma S, Dudeja P, Puri P. A
descriptive study of clinico-hematological prole of
megaloblastic anemia in a tertiary care hospital. Med
J Armed Forces India. 2018;74(4):365–70. https://doi.
org/10.1016/j.mja.2017.11.005. Epub 2017 Dec 27.
PMID: 30449923; PMCID: PMC6224687.
32. Vaggu SK, Bhogadi P. Bilateral macular hemorrhage due to megaloblastic anemia: a rare case report.
Indian J Ophthalmol. 2016;64(2):157–9. https://doi.
org/10.4103/0301- 4738.179720. PMID: 27050355;
PMCID: PMC4850815.
33. Mansour AM, Salti HI, Han DP, Khoury A,
Friedman SM, Salem Z, Ibrahim K, Bazerbachi
A, Saghir N. Ocular ndings in aplastic anemia.
Ophthalmologica. 2000;214(6):399–402. https://doi.
org/10.1159/000027532. PMID: 11053999.
34. Toh ZH, Chin CF, Gan NY.Case of unilateral anaemic retinopathy unmasking colorectal carcinoma.
BMJ Case Rep. 2022;15(2):e248029. https://doi.
org/10.1136/bcr- 2021- 248029. PMID: 35228244;
PMCID: PMC8886398.
35. Liu TYA, Johnson TV, Barnett BP, Scott AW.Evolution
of leukemic retinal hemorrhages documented by
spectral-domain OCT and color fundus photography.
Ophthalmol Retina. 2018;2(5):494–501. https://doi.
org/10.1016/j.oret.2017.08.014. Epub 2017 Oct 18.
PMID: 31047332.
36. Rodrigues GR, Mendonca TM.Retinal hemorrhages
in leukemia. N Engl J Med. 2022;386(19):e50. https://
doi.org/10.1056/NEJMicm2116866. Epub 2022 May
7. PMID: 35522023.
37. Zhuang I, Gupta I, Weng CY. Retinal hemorrhages
in a patient with petechiae. JAMA Ophthalmol.
2019;137(4):459–60. https://doi.org/10.1001/
jamaophthalmol.2018.6220. Erratum in: JAMA
Ophthalmol. 2020;138(2):223. PMID: 30763438.
38. Dobberstein H, Solbach U, Weinberger A, Wolf
S. Correlation between retinal microcirculation and
blood viscosity in patients with hyperviscosity syndrome. Clin Hemorheol Microcirc. 1999;20(1):31–5.
PMID: 11185681.
39. da Cruz NFS, Milhomens Filho JAP, Ferraro
DMN, Polizelli MU, de Moraes Ambrogini

References
https://t.me/medicina_free
99
NSB. Hyperviscosity retinopathy and immunogammopathy maculopahy as new onset of multiple
myeloma. Case Rep Ophthalmol. 2021;12(2):578–
84. https://doi.org/10.1159/000514695. PMID:
34326757; PMCID: PMC8299375.
40. Choi RY, Jacoby R, Shakoor A. Multimodality
ocular imaging in a case report of hyperviscosity
syndrome associated with lymphoplasmacytic leukemia: the images tell the story. Retin Cases Brief
Rep. 2019;13(3):238–40. https://doi.org/10.1097/
ICB.0000000000000565. PMID: 28333850.
41. Rachidi S, Musallam KM, Taher AT.A closer look at
paroxysmal nocturnal hemoglobinuria. Eur J Intern
Med. 2010;21(4):260–7. https://doi.org/10.1016/j.
ejim.2010.04.002. Epub 2010 May 13. PMID:
20603032.
42. Meppiel E, Crassard I, Latour RP, de Guibert S,
Terriou L, Chabriat H, Socié G, Bousser MG.Cerebral
venous thrombosis in paroxysmal nocturnal hemoglobinuria: a series of 15 cases and review of the literature. Medicine (Baltimore). 2015;94(1):e362. https://
doi.org/10.1097/MD.0000000000000362. PMID:
25569655; PMCID: PMC4602837.
43. Hauser D, Barzilai N, Zalish M, Oliver M, Pollack
A. Bilateral papilledema with retinal hemorrhages
in association with cerebral venous sinus thrombosis and paroxysmal nocturnal hemoglobinuria.
Am J Ophthalmol. 1996;122(4):592–3. https://
doi.org/10.1016/s0002- 9394(14)72130- 0. PMID:
8862066.
44. Scheuerle AF, Serbecic N, Beutelspacher
SC. Paroxysmal nocturnal hemoglobinuria may
cause retinal vascular occlusions. Int Ophthalmol.
2009;29(3):187–90. https://doi.org/10.1007/s10792-
007- 9188- 9. Epub 2008 Apr 24. PMID: 18437293.
45. Sorigue M, Juncà J, Orna E, Romanic N, Sarrate E,
Castellvi J, Soler M, Rodríguez-Hernandez I, Feliu
E, Ruiz S. Retinal vein occlusion and paroxysmal
nocturnal hemoglobinuria. J Thromb Thrombolysis.
2017;44(1):63–6. https://doi.org/10.1007/s11239-
017- 1502- 4. PMID: 28447244.
46. Sim R, Cheung G, Ting D, Wong E, Wong TY, Yeo I,
Wong CW.Retinal microvascular signs in COVID-19.
Br J Ophthalmol. 2022;106(9):1308–12. https://doi.
org/10.1136/bjophthalmol- 2020- 318236. Epub ahead
of print. PMID: 33741583; PMCID: PMC7985973.
47. Bosch MM, Barthelmes D, Landau K. High altitude retinal hemorrhages—an update. High Alt Med
Biol. 2012;13(4):240–4. https://doi.org/10.1089/
ham.2012.1077. PMID: 23270439.
48. Takkar A, Kesav P, Lal V, Gupta A. Teaching neuroimages: Terson syndrome in cortical venous sinus
thrombosis. Neurology. 2013;81(6):e40–1. https://
doi.org/10.1212/WNL.0b013e31829e6f13. PMID:
23918868.
49. Verma R, Sahu R, Lalla R.Subarachnoid haemorrhage
as the initial manifestation of cortical venous thrombosis. BMJ Case Rep. 2012;2012:bcr2012006498.
https://doi.org/10.1136/bcr- 2012- 006498. PMID:
22914236; PMCID: PMC4543949.
50. Wall M. Idiopathic intracranial hypertension. Neurol
Clin. 2010;28(3):593–617. https://doi.org/10.1016/j.
ncl.2010.03.003. PMID: 20637991; PMCID:
PMC2908600.
51. Raevis J, Elmalem VI.Pseudotumor cerebri syndrome
causing a terson like syndrome. Am J Ophthalmol
Case Rep. 2020;20:100993. https://doi.org/10.1016/j.
ajoc.2020.100993. PMID: 33305067; PMCID:
PMC7710506.
52. Voldman A, Durbin B, Nguyen J, Ellis B, Leys
M. Fulminant idiopathic intracranial hypertension
and venous stasis retinopathy resulting in severe
bilateral visual impairment. Eur J Ophthalmol.
2017;27(2):e25–7. https://doi.org/10.5301/
ejo.5000918. PMID: 28009405.
53. Younus O, Savides P. Papilloedema with retinal
haemorrhages in idiopathic intracranial hypertension. BMJ Case Rep. 2022;15(2):e248912. https://
doi.org/10.1136/bcr- 2022- 248912. PMID: 35228253;
PMCID: PMC8886392.
54. Brodsky MC, Biousse V. A bloody mess! Sur
Ophthalmol. 2018;63(2):268–74. https://doi.
org/10.1016/j.survophthal.2017.05.004. Epub 2017
May 18. PMID: 28527856.
55. Ozgonul C, Moinuddin O, Munie M, Lee MS, Bhatti
MT, Landau K, Van Stavern GP, Mackay DD, Lebas M,
DeLott LB, Cornblath WT, Besirli CG. Management
of peripapillary choroidal neovascular membrane
in patients with idiopathic intracranial hypertension. J Neuroophthalmol. 2019;39(4):451–7. https://
doi.org/10.1097/WNO.0000000000000781. PMID:
30951011; PMCID: PMC8063500.
56. Cogan DG, Victor M. Ocular signs of
Wernicke’s disease. AMA Arch Ophthalmol.
1954;51(2):204–11. https://doi.org/10.1001/archo
pht.1954.00920040206007. PMID: 13123606.
57. Thomson AD, Cook CC, Guerrini I, Sheedy D,
Harper C, Marshall EJ. Wernicke’s encephalopathy
revisited. Translation of the case history section of
the original manuscript by Carl Wernicke ‘Lehrbuch
der Gehirnkrankheiten fur Aerzte and Studirende’
(1881) with a commentary. Alcohol Alcohol.
2008;43(2):174–9. https://doi.org/10.1093/alcalc/
agm144. Epub 2007 Dec 4. PMID: 18056751.
58. Bohnsack BL, Patel SS.Peripapillary nerve ber layer
thickening, telangiectasia, and retinal hemorrhages
in wernicke encephalopathy. J Neuroophthalmol.
2010;30(1):54–8. https://doi.org/10.1097/
WNO.0b013e3181ceb4d0. PMID: 20182209.
59. Mumford CJ. Papilloedema delaying diagnosis of
Wernicke’s encephalopathy in a comatose patient.
Postgrad Med J. 1989;65(764):371–3. https://doi.
org/10.1136/pgmj.65.764.371. PMID: 2608577;
PMCID: PMC2429353.
60. Pereira FB, Soares Dutra Oliveira H, Lima VC,
Lima LH, Balaratnasingam C, Pulido JS, de Souza
EC. Retinal hemorrhages in a patient with acute
ataxia. Retin Cases Brief Rep. 2021;15(Suppl 1):S32–
4. https://doi.org/10.1097/ICB.0000000000001149.
PMID: 34171899.

100
https://t.me/medicina_free
5 Retinal Haemorrhages
61. Brown GC, Magargal LE. The ocular ischemic
syndrome. Clinical, uorescein angiographic and
carotid angiographic features. Int Ophthalmol.
1988;11(4):239–51. https://doi.org/10.1007/
BF00131023. PMID: 3182177.
62. Vazirani JA, Zadeng Z, Dogra MR, Gupta
A. Ocular ischemic syndrome. Indian J
Ophthalmol. 2014;62(5):658–60. https://doi.
org/10.4103/0301- 4738.97083.
63. Hussain N, Falali S, Kaul S.Carotid artery disease
and ocular vascular disorders. Indian J Ophthalmol.
2001;49(1):5–14. Erratum in: Indian J Ophthalmol.
2001;49(3):150. PMID: 15887709.
64. Roy MS, McCulloch JC. Peripheral retinal hemorrhages in long-duration insulin-dependent diabetes with minimal background retinopathy. Br
J Ophthalmol. 1982;66(5):286–9. https://doi.
org/10.1136/bjo.66.5.286. PMID: 7074003; PMCID:
PMC1039781.
65. Galvin R, Sanders MD. Peripheral retinal haemorrhages with papilloedema. Br J Ophthalmol.
1980;64(4):262–6. https://doi.org/10.1136/
bjo.64.4.262. PMID: 7387960; PMCID:
PMC1043666.
66. Duane TD.Valsalva hemorrhagic retinopathy. Trans
Am Ophthalmol Soc. 1972;70:298–313. PMID:
4663671; PMCID: PMC1310456.
67. Mathew DJ, Sarma SK. Valsalva retinopathy with
double ring sign: laser membranotomy for twin bleeds.
Saudi J Ophthalmol. 2016;30(1):68–70. https://doi.
org/10.1016/j.sjopt.2015.10.003. Epub 2015 Oct 30.
PMID: 26949364; PMCID: PMC4759518.
68. Kadrmas EF, Pach JM.Vitreous hemorrhage and retinal vein rupture. Am J Ophthalmol. 1995;120(1):114–
5. https://doi.org/10.1016/s0002- 9394(14)73769- 9.
PMID: 7611317.
69. Flikier S, Flikier D, Flikier B, Wu L. Multimodal
imaging of valsalva petaloid maculopathy secondary
to acute laryngospasm and endotracheal intubation.
Eur J Ophthalmol. 2022;32(2):NP6–NP10. https://
doi.org/10.1177/11206721211032515.
70. Patane PS, Krummenacher TK, Rao RC. Valsalva
hemorrhagic retinopathy presenting as a rare cause
of impaired vision after a general anesthetic—
a case report and review of the literature. J Clin
Anesth. 2015;27(4):341–6. https://doi.org/10.1016/j.
jclinane.2015.03.013. Epub 2015 Apr 9. PMID:
25865821.
71. Mutha V, Narde HK, Chandra P, Kumar
A. Valsalva retinopathy following normal vaginal delivery: ‘bilaterality a rarity’. BMJ Case Rep.
2018;2018:bcr2018224781. https://doi.org/10.1136/
bcr- 2018- 224781. PMID: 29666102; PMCID:
PMC5905816.
72. Leisser C, Huemer JC, Findl O. Henle bre layer
haemorrhage after a valsalva manoeuvre. Case
Rep Ophthalmol. 2021;12(1):105–9. https://doi.
org/10.1159/000511373. PMID: 33976665; PMCID:
PMC8077655.

New Vessels ontheOptic Disc
https://t.me/medicina_free
andElsewhere intheRetina
6
6.1 Introduction
Development of pathological new vessels on the
optic disc (NVD), new vessels elsewhere in the
retina (NVE), and uncommonly, the anterior segment of the eye is the most signicant and sightthreatening complication of diabetes mellitus
(DM) and the common cause of severe visual loss
in the developed world. According to the
International Diabetes Federation, in 2021, 537
million people worldwide were living with diabetes, estimated to go up to 783 million by 2045.
Moreover, 541 million people will have impaired
glucose tests in 2021. It is anticipated that nearly
6.7 million people will die from diabetes and its
related complications in 2021, making it one of
the fastest-growing public health emergencies
[1]. Diabetes is also the most common cause of
blindness or severe visual impairment in the
working-age group in the developed world. Given
the critical role that physicians and ophthalmologists play in avoiding this unnecessary blindness,
we discuss in some detail the pathophysiological
mechanisms that lead to blindness in DM.
The severest form of symmetrical bilateral
pathological neovascularization, the bane of
middle- and low-income regions of the world,
termed retinopathy of prematurity (ROP), is seen
in preterm babies and, if not recognized and
timely treated in an extremely narrow window of
opportunity, leads to irreversible blindness.
Autosomal dominant familial exudative vitreo-
retinopathy (FEVR) is a rare cause of peripheral
pathological brovascular proliferation, almost
similar to ROP in appearance, bilateral but
highly asymmetric, and without a history of prematurity or oxygen therapy. The other, not
uncommon, causes include ischaemic branch
retinal vein occlusion, ischaemic central retinal
vein occlusion, inammatory occlusion of the
retinal veins, sickle cell retinopathies, and atherosclerotic and inammatory carotid artery diseases (see Box 6.1). The development of
abnormal vessels in the retina is a highly complex phenomenon and, in the last several decades,
has continued to be a subject of intense research
to unravel the mystery of the highly orchestrated
biological interactions that underpin the development of abnormal vasculature. We shall briey
discuss the pathophysiological mechanisms
underlying abnormal retinal vascularization
development.
Box 6.1 Common Causes of Retinal New
Vessels
1 Proliferative diabetic retinopathy
2 Ischaemic retinal venous occlusion
3 Retinopathy of prematurity
4 Ischaemic retinal periphlebitis
5 Sickle cell anemia
6 Familial exudative vitreoretinopathy
7 Ocular ischaemic syndrome
© The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2023
A. Gupta et al., Ophthalmic Signs in Practice of Medicine,
https://doi.org/10.1007/978-981-99-7923-3_6
101

102
https://t.me/medicina_free
6 New Vessels ontheOptic Disc andElsewhere intheRetina
6.1.1 Blood Supply oftheRetina
The retina is metabolically one of the most active
tissues of the body. While the photoreceptors in the
outer retina get their oxygen supply from the choroid, the inner retina gets its oxygen and micronutrient requirements through a 3-tiered capillary
distribution network of the central retinal artery.
Like other natural phenomena, such as the branches
of a tree or the bronchial tree, the blood supply in
the human body and the retinal blood supply follows a complex fractal geometry (cf. Euclidean
geometry that follows straight lines) to maximize
the distribution of blood supply in a conned space.
Quantifying the various aspects of retinal vessel
geometry, including their fractal dimensions, is
now possible using digital images or digitizing
them. The fractal dimension, a measure of the complexity of the retinal vessels, has been calculated as
1.7 [2]. While the choroidal blood vessels that supply the oxygen and micronutrients to the photoreceptors are under autonomic control, autoregulation
at the level of the neuro-glial-vascular unit controls
the blood supply to meet the metabolic requirements of the neural elements in the inner retina.
The fractal geometry of the retinal vessels ensures
a uniform blood ow and supply and removal of
the metabolites from the inner retina.
side of the inner nuclear layer. The perifoveal
area always remains avascular. In the past, it has
been debated whether the retinal vasculature
develops by vasculogenesis or angiogenesis. In
Ang-2 decient transgenic mice, the hyaloid vessels being vasculogenic in origin were present.
However, the retina remained avascular, settling
the issue of retinal vasculature development in
favour of angiogenesis. VEGF-A and Ang-1 play
a signicant role in the embryonic development
of retinal vasculature, but Ang-2 is necessary for
post-natal remodelling of the retinal vessels [4].
It is currently believed that cellular interactions
between the retinal ganglion cells (RGC), retinal
astrocytes (derived from the optic nerve head;
these migrate into the nerve bre layer), and the
endothelial cells lead to the development of normal retinal vessels. The development of the retinal vasculature is mediated by the platelet-derived
growth factor A from the RGC, the plateletderived growth factor B from the endothelial
cells, and the VEGF gradient that exists due to
hypoxia in the retinal tissue [5].
6.2 Pathophysiology ofDiabetic
Retinopathy
6.2.1 Muller Cells
6.1.2 Development ofNormal
Retinal Vessels
Normal retinal vasculature develops initially as
capillary plexuses around the optic disc that
extends peripherally, the rst to start is the supercial capillary plexus (SCP) in the retinal nerve
bre layer and the ganglion cells beginning at
about 14–16weeks of gestation and the deep capillary plexus (DCP) on either side of the inner
nuclear layer about 8 weeks later. The DCP
always lags behind the SCP.Even at full term, the
temporal SCP is yet to develop. The retinal arterioles and veins differentiate from these plexuses
[3]. The capillaries are believed to grow in retinal
tissue planes that offer the least resistance,
namely the nerve bre layer, the inner plexiform,
and the outer plexiform layer that lies on either
Each retinal capillary cell shares a very intimate
relationship with the processes of the Muller
cells, the macroglia cells, and the resident macrophages, the microglial cells. The non-activated
microglia lie in the inner and outer plexiform layers. Once activated, they assume the functions of
a macrophage, move throughout the retina, and
produce inammatory cytokines. The Muller cell
processes extend throughout the thickness of the
neurosensory retina, and their footplates form the
internal elastic lamina (ILM). The outer limiting
membrane is formed by the contact of the Muller
cell processes with the photoreceptors at the
junction of their inner and outer segments. These
processes maintain intimate contact with the capillary endothelial cells, retinal ganglion cells,
bipolar cells, horizontal cells, amacrine cells, and
the photoreceptors to form a neuro-glia-vascular

6.2 Pathophysiology ofDiabetic Retinopathy
https://t.me/medicina_free
103
unit, commonly called a neurovascular unit. The
primary function of this unit is to maintain metabolic homeostasis in the retina by controlling
glucose metabolism. The Muller cells remove the
toxic glutamate, prevent oxidative damage, and
recycle neurotrophic factors critical for cell survival [6].
The hypoxic milieu in the retina, as in diabetic
retinopathy, leads to the overexpression of
hypoxia-inducible factor 1-α (HIF-1α) in the
endothelial cells and the Muller cells. Hypoxic
Muller cells also produce VEGF, leading to overexpression of the matrix metallic proteinase-2
(MMP-2) by the endothelial cells. Typically, the
tissue inhibitors of matrix metalloproteinase
(TIMP-2) are in a strict balance with the MMP-2,
but in a diseased state, this balance is disturbed.
While HIF-1α is a regulator of vascular endothelial growth factor (VEGF) that promotes neovascular budding, MMP-2 leads to proteolysis of the
extracellular matrix essential for the growth of
new vessels outside the retina [7]. It is to be noted
that VEGF is involved in both the hypoxiainduced physiological as well as pathological
development of retinal vessels. In a mouse model,
VEGF
was overexpressed in the pathological
164
development of new vessels compared to their
physiological development [8].
6.2.2 Pericytes-Endothelial Cell
Interaction
Pericytes are intimately connected with the endothelial cells of the capillaries in all organs and
play a signicant role in the control of microcirculation because of their contractile properties.
Relaxation of pericytes causes increased capillary blood ow, and contraction does the opposite
[9]. Electron microscopic studies in the human
retina have shown that pericytes cover more than
85% of the endothelial cells, much greater coverage than seen in the cerebral cortex or any other
organ [10]. A basement membrane surrounds the
endothelial cells, and another surrounds the
pericyte- endothelial cell complex. Pericytes
appear buried in the basement of the endothelial
cells. Pericytes play a signicant role in checking
endothelial cell proliferation. Furthermore, the
pericytes regulate the expression of tight junction
proteins that maintain the inner blood-retinal barrier. Pores (gap junctions) in the extracellular
matrix (ECM) of the basement membrane (BM)
allow for the cell-to-cell crosstalk between the
pericytes and the endothelial cells [11]. It is to be
noted that pericytes do not have the potential to
regenerate, while endothelial cells can proliferate. The vascular endothelial cells and pericytes
share similar insulin receptors. One of the signicant characteristics of diabetic microvascular disease is insulin resistance by the endothelial cells
and impaired endothelial repair by the endothelial progenitor cells [12]. Recently, a decrease in
insulin-stimulated Angiopoetin-1 (Ang-1) secretion in a pericyte insulin receptor knock-out mice
model led to reduced angiopoietin-Tie2 signalling. It caused excessive vascular abnormalities
mimicking diabetic retinopathy [13]. The authors
proposed that Insulin signalling controls Ang-1
secretion from the pericytes in a healthy state.
Ang-1, in turn, interacts with the Tie-2 receptors, the transmembrane tyrosine kinase receptors on the endothelial cells, and ensures vascular
stability by preventing transcription of the Ang-2.
In diabetes, lack of insulin signalling results in
decreased Ang-1 release to interact with the Tie-2
receptors and leads to overexpression of Ang-2, a
factor in angiogenic sprouting [13]. Ang-2
expression increases in several diseases, such as
cancer, sepsis, and diabetes. Ang-2 blocking
agents restore the normalcy of sprouting vessels
[14]. Moreover, Ang-2, a competitive antagonist
of Ang-1, also turns off the Tie-2 receptor, setting
the stage for increased endothelial permeability
and angiogenesis [15]. Simultaneous use of a
bispecic Ang-2 and VEGF-A blocking agent,
Faricimab, has shown promising results in treating diabetic macular oedema [16]. This drug is
currently FDA-approved for treating diabetic
macular oedema and neovascular AMD.

104
https://t.me/medicina_free
6 New Vessels ontheOptic Disc andElsewhere intheRetina
6.2.3 Thickening ofBasement
Membrane inDiabetes
Mellitus
One of the earliest pathological changes noted in
the capillaries all over the body is the thickening
of the basement membrane (BM) surrounding the
endothelial cells, which is most profound in the
retinal capillaries. The thickening occurs because
of the deposition of the extracellular matrix
(ECM) proteins in the basement membrane of the
capillaries due to the non-enzymatic glycation of
proteins (advanced glycation end products—
AGE) in the presence of long-term hyperglycemia. At least 17 proteins, including collagen IV
and bronectin, were found overexpressed and
four under-expressed in the diabetic basement
membranes compared to those from the
non- diabetic human donor eye specimens.
Diabetes- related proteins were found to be more
abundant in the area of microaneurysms. The
deposition of these ECM proteins caused a doubling of the thickness of the BM. Two components of the complement family, C4 and C9, were
also exclusively detected in the diabetic BM, suggesting a role for complement-mediated chronic
inammation in diabetic retinopathy.
Contrary to the belief that thick BM in people
with diabetes is stiffer, atomic force microscopy
revealed the BM in diabetics to be softer.
Additionally, norrin—a growth factor protein
associated with vascular proliferation—was
upregulated in the BM [17]. Apart from providing structural support to the vascular endothelial
cells, the BM plays a signicant role in maintaining homeostasis, provides an additional
blood- retinal permeability barrier, controls pericyte contraction, promotes cell-to-cell communication, plays a role in apoptosis, and is a
repository of growth factors that promote new
vessel growth [18]. Research is going on to regulate the genetic mechanisms that lead to the
deposition of the ECM in the basement membrane as a strategy to prevent the development of
diabetic retinopathy [18].
6.2.4 Consequences
oftheBasement Membrane
Thickening
One of the consequences of the thickened BM is
the loss of pericytes due to poor cell-matrix adhesions. It is one of the earliest pathological lesions
in diabetic retinopathy [19, 20].
It is likely that a thickened BM also causes a
breakdown in the cell-to-cell communication
between the Muller cells, pericytes, and endothelial cells, leading to a loss of the auto-regulatory
control by this neurovascular unit leading to a
state of hypoxia, which also leads to activation of
the microglia, and the Muller cells throughout the
thickness of the retina [11]. Once activated, the
microglia assume phagocytic activity and release
proinammatory cytokines.
6.2.5 Formation ofAcellular Retinal
Capillaries
Loss of the endothelial cells and the pericytes
leads to forming acellular capillaries seen in trypsin digest studies as BM-bound hollow tubes.
These hollow tubes lie next to the retinal arterioles. The activated microglia assume the role of
macrophages to phagocytose the cellular debris.
These are visible as capillary non-perfusion
(CNP) areas on fundus uorescein angiography
(Figs.6.1 and 6.2). The CNP areas are the hallmark of retinal ischaemia and mark the beginning
of clinical manifestations of diabetic retinopathy,
ultimately leading to abnormal vessels that grow
into the vitreous cavity. Several mechanisms may
be responsible for the loss of pericytes.
Upregulation of Ang-2 (discussed in Sect. 6.1.4)
in the presence of high blood glucose leads to
apoptosis or migration of the pericytes. Advanced
glycation end products are accumulated in the
pericytes; inammatory pathways via retinal
autoantibodies against the pericytes through
complement activation or accumulation of oxidative LDL products may also play a role. Activation
Соседние файлы в папке Библиотека им академика М.И. Перельмана
